NCT00128115终止2 期
Proprietary Information - Exploratory (Non-Confirmatory) Trial
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 83
- 试验地点
- 10
- 主要终点
- Proprietary Information - Exploratory (Non-Confirmatory) Trial
研究概览
简要总结
The purpose of this study is to demonstrate an improvement in physical functional recovery, following administration of Drug for 24 weeks, in patients who have recently experienced a hip fracture. This study will also evaluate the safety and tolerability of Drug.
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient has had surgery for a unilateral hip fracture, and is considered to be partially or fully weight bearing after the surgery
- •Surgical repair of the fracture has occurred no more than 4 days post hip fracture
- •Prior to starting the study medication, the patient is enrolled in a rehabilitation program (as an in-patient or as an out-patient)
- •Patient is judged to have been able to ambulate independently at home prior to their hip fracture (able to walk indoors in a familiar setting with little or no aid from another person)
排除标准
- •Patient has an unstable medical condition
- •Patient has a hip fracture that is due to bone pathology other than osteoporosis (e.g., malignancy, or Paget's Disease), or major trauma (e.g. motor vehicle accident).
- •Patient has Type I diabetes
- •Patient has Type II diabetes with any of conditions;
- •Patient is currently taking more than one anti-hyperglycemic agent, or is taking a single combination anti-hyperglycemic drug containing more than one anti-hyperglycemic medication
- •Patient is currently receiving insulin. Note: A short-term course of insulin required for glycemic control post hip fracture surgery is not exclusionary
- •Patient has diabetic retinopathy
- •Patient is unwilling or unable to monitor glucose at home
- •Patient has been diagnosed with any neuromuscular or neurological disease causing muscle weakness
- •Patient has cancer, or had a diagnosis of any malignancy within the last 5 years, except for adequately treated basal cell or squamous cell skin cancer, or adequately treated in situ cervical cancer
- •Patient has active carpal tunnel syndrome
- •Patient was living in a nursing home prior to the hip fracture (Note: - Patients who were living in an assisted-living facility prior to the hip fracture are eligible for enrollment)
- •Patient was permanently wheelchair bound prior to the hip fracture
结局指标
主要结局
Proprietary Information - Exploratory (Non-Confirmatory) Trial
次要结局
- Proprietary Information - Exploratory (Non-Confirmatory) Trial
研究者
研究点 (10)
Loading locations...
相似试验
已完成
不适用
Recovery through healthy living in acute psychiatric settingISRCTN37185489niversity of Warwick (UK)100
已完成
不适用
Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced DyspnoeaChronic Obstructive Pulmonary DiseaseNCT00540163Boehringer Ingelheim1,296
招募中
不适用
To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor SurgeryEnhanced Recovery After SurgeryPostoperative ComplicationsPituitary TumorNCT06221020Chang Gung Memorial Hospital70
招募中
不适用
Muscle Recovery After Critical IllnessICU Acquired WeaknessPost Intensive Care Unit SyndromeMuscle WeaknessCritical IllnessNCT05537298Esther Dupont-Versteegden209
已完成
不适用
Observational Non-Interventional Study With Spiriva Respimat in COPD PatientsPulmonary Disease, Chronic ObstructiveNCT00699699Boehringer Ingelheim1,280